Why the study?
PPVI is used to treat PS or PR, and the authors sought to describe their experience with Melody and novel self-expandable Pulsta valves in Korea.
Does percutaneous pulmonary valve implantation with Melody or Pulsta valves improve hemodynamics and provide safe early outcomes in patients with RVOT dysfunction?
Population
42 patients undergoing PPVI in Korea
Design
Retrospective cohort study
Follow-up
Mean 14.2 month (4–57 months)
Authors
Loading...
May inform PPVI valve selection in select patients; hypothesis-generating and leaves open durability and comparative outcomes.
Does percutaneous pulmonary valve implantation with Melody or Pulsta valves improve hemodynamics and provide safe early outcomes in patients with RVOT dysfunction?
Percutaneous pulmonary valve implantation using Melody and Pulsta valves provides excellent early hemodynamic improvements and safety in Korean patients with RVOT dysfunction.
Kim et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: